NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-244-2015-0-US-01 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use US 62/200,438 Abandoned
NHLBI E-037-2011-0-IL-09 Development Of A Novel HDL Based Hydrophobic Drug Delivery System Using Amphipathic Peptides IL National Stage 237142 Pending
NCI E-162-2014-0-CN-03 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE CN National Stage 201580050476.9 Issued
NCI E-162-2014-0-US-06 Human Monoclonal Antibodies Against EphA4 and Their Use US National Stage 15/329,659 10934360 Issued PDF
NCI E-162-2014-0-EP-04 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE EP National Stage 15827008.2 Issued
NCI E-162-2014-0-GB-15 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE GB EP 15827008.2 Issued
NCI E-162-2014-0-DE-12 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE DE EP 15827008.2 Issued
NCI E-162-2014-0-IT-16 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE IT EP 15827008.2 Issued
NCI E-162-2014-0-ES-13 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE ES EP 15827008.2 Issued
NCI E-162-2014-0-CH-11 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE CH EP 15827008.2 Issued
NCI E-162-2014-0-FR-14 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE FR EP 15827008.2 Issued
NCI E-162-2014-0-JP-05 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE JP National Stage 2017-505223 Issued
NHLBI E-068-2016-1-PCT-02 THE EFFECT OF PHOSPHOLIPID COMPOSITION OF RECONSTITUTED HDL ON ITS CHOLESTEROL EFFLUX AND ANTI-INFLAMMATORY PROPERTIES PCT PCT PCT/US2015/043281 Expired
NCI E-162-2014-0-PCT-02 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE PCT PCT PCT/US2015/043182 Expired
NHLBI E-068-2016-1-US-01 EFFECT OF PHOSPHOLIPID COMPOSITION OF RECONSTITUTED HDL ON ITS CHOLESTEROL EFFLUX AND ANTI-INFLAMMATORY PROPERTIES US ORD 14/815,683 Abandoned
NINDS E-014-2006-2-JP-47 Assays For Diagnosing and Evaluating Treatment Options for Fabry Disease JP DIV 2015-151795 Abandoned
NCI E-240-2015-0-US-01 METHODS OF ANALYSIS OF RNA VIRUS-DERIVED THERAPEUTICS US 62/199,663 Abandoned
NCI E-171-2018-0-US-01 NON-VIRAL TCR MODIFIED CELLS AND METHODS OF THERAPY US 62/199,905 Abandoned
NCI E-142-2014-0-US-01 Antigen-Binding Proteins Targeting CD56 And Uses Thereof US 62/199,775 Abandoned
NCI E-221-2015-0-US-01 ANTIBODY-DRUG CONJUGATES FOR TARGETING CD56-POSITIVE TUMORS US 62/199,707 Abandoned
NEI E-251-2012-3-US-03 Methods For Generating Retinal Pigment Epithelium (RPE) Cells From Induced Pluripotent Stem Cells (IPSCS) US National Stage 14/764,959 Abandoned
NICHD E-339-2008-2-US-07 A Mutlicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia US DIV 14/814,256 Abandoned
CC E-093-2014-2-PCT-01 FREE HORMONE AND HORMONE METABOLITE WORKUP AND ANALYSIS BY MASS SPECTROMETRY PCT PCT COMB PCT/US2015/042689 Abandoned
NCI E-251-2015-0-US-01 OPTICAL TRAP FOR RHEOLOGICAL CHARACTERIZATION OF COMPLEX MATERIALS US 62/198,554 Abandoned
NCI E-070-2015-0-EP-03 IL-·15 AND IL-15RALPHA HETERODIMER DOSE ESCALATION REGIMENS FOR TREATING CONDITIONS EP National Stage 15828027.1 Issued
NCI E-070-2015-0-JP-04 IL-·15 AND IL-15RALPHA HETERODIMER DOSE ESCALATION REGIMENS FOR TREATING CONDITIONS JP National Stage 2017-504713 Issued
NIAID E-223-2014-0-PCT-02 Compositions and Methods for Inhibiting Human Immunodeficiency Virus Budding PCT PCT PCT/US2015/042492 Expired
NCI E-070-2015-0-PCT-02 IL-·15 AND IL-15RALPHA HETERODIMER DOSE ESCALATION REGIMENS FOR TREATING CONDITIONS PCT PCT PCT/US2015/042489 Expired
NIAID E-209-2016-0-EP-01 SINGLE DOMAIN ANTIBODY AGAINST RSV F PROTEIN EP ORD 15178653.0 Abandoned
NCI E-291-2014-0-CA-05 Method For Purifying Antibody Using PBS CA National Stage 2956316 Issued
NCI E-291-2014-0-CN-06 Method For Purifying Antibody Using PBS CN National Stage 201580050412.9 Issued
NCI E-291-2014-0-EP-04 Method For Purifying Antibody Using PBS EP National Stage 15750191.7 Issued
NIAID E-007-2015-0-US-05 CD47-targeted Therapies For The Treatment Of Infectious Disease US National Stage 14/763,758 9771428 Issued PDF
NCI E-291-2014-0-PCT-03 METHOD FOR PURIFYING ANTIBODIES PCT PCT PCT/US2015/042241 Expired
NCI E-255-2015-0-JP-01 Selective Propagation, Maintenance, And Induction Of Nephron Stem Cells JP ORD 2015-139271 Pending
NCI E-291-2014-0-US-02 Method For Purifying Antibodies Using PBS US ORD 14/809,211 10329323 Issued PDF
NCI E-108-2004-1-CA-09 METHODS FOR IDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS CA DIV 2897828 Issued
NCI E-020-2013-0-US-04 Compositions and Methods for Detecting Neoplasia US National Stage 14/762,426 10487363 Abandoned PDF
NEI E-162-2016-0-EP-10 GENE THERAPY FOR RETINITIS PIGMENTOSA EP DIV 20199208.8 Issued
NEI E-162-2016-0-CA-04 GENE THERAPY FOR RETINITIS PIGMENTOSA CA National Stage 2991750 Issued
NEI E-162-2016-0-CY-28 GENE THERAPY FOR RETINITIS PIGMENTOSA CY EP 15825383.1 Issued
NEI E-162-2016-0-BG-12 GENE THERAPY FOR RETINITIS PIGMENTOSA BG EP 15825383.1 Issued
NEI E-162-2016-0-LU-22 GENE THERAPY FOR RETINITIS PIGMENTOSA LU EP 15825383.1 Issued
NEI E-162-2016-0-LV-23 GENE THERAPY FOR RETINITIS PIGMENTOSA LV EP 15825383.1 Issued
NEI E-162-2016-0-IT-21 GENE THERAPY FOR RETINITIS PIGMENTOSA IT EP 15825383.1 Issued
NEI E-162-2016-0-BE-11 GENE THERAPY FOR RETINITIS PIGMENTOSA BE EP 15825383.1 Issued
NEI E-162-2016-0-IS-20 GENE THERAPY FOR RETINITIS PIGMENTOSA IS EP 15825383.1 Issued
NEI E-162-2016-0-DE-13 GENE THERAPY FOR RETINITIS PIGMENTOSA DE EP 15825383.1 Issued
NEI E-162-2016-0-GR-29 GENE THERAPY FOR RETINITIS PIGMENTOSA GR EP 15825383.1 Issued
NEI E-162-2016-0-HU-30 GENE THERAPY FOR RETINITIS PIGMENTOSA HU EP 15825383.1 Issued